XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating activities    
Net income (loss) from continuing operations $ 442,000 $ (603,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities    
Depreciation, depletion, and amortization 795,000 862,000
Amortization of loan fees-interest expenses 4,000 20,000
Accretion of discount on asset retirement obligation 141,000 141,000
(Gain) loss on asset sales (33,000) (2,000)
Compensation and services paid in stock / stock options 23,000 14,000
Changes in assets and liabilities:    
Accounts receivable 96,000 (318,000)
Inventory, prepaid expense, and other assets (28,000) 203,000
Accounts payable (58,000) (78,000)
Accrued liabilities (64,000) (73,000)
Settlement on asset retirement obligations (25,000) (53,000)
Net cash provided by operating activities - continuing operations 1,293,000 113,000
Net cash provided by operating activities - discontinued operations 44,000 41,000
Net cash provided by operating activities 1,337,000 154,000
Investing activities    
Additions to oil and gas properties (1,011,000) (169,000)
Proceeds from sale of oil and gas properties 7,000 7,000
Additions to other property and equipment (27,000) (17,000)
Proceeds from sale of other property and equipment 8,000  
Net cash used in investing activities - continuing operations (1,023,000) (179,000)
Net cash provided by investing activities - discontinued operations 2,658,000  
Net cash provided by (used in) investing activities 1,635,000 (179,000)
Financing activities    
Proceeds from stock issuance in rights offering   2,699,000
Cost of stock issuance in rights offering   (102,000)
Proceeds from borrowings 100,000 400,000
Repayment of borrowings (142,000) (2,854,000)
Loan fees   (9,000)
Net cash provided by (used in) financing activities - continuing operations (42,000) 134,000
Net cash provided by (used in) financing activities (42,000) 134,000
Net change in cash and cash equivalents 2,930,000 109,000
Cash and cash equivalents, beginning of period 185,000 76,000
Cash and cash equivalents, end of period 3,115,000 185,000
Supplemental cash flow information:    
Cash interest payments   33,000
Supplemental non-cash investing and financing activities:    
Financed company vehicles 136,000 81,000
Cost of stock issuance in rights offering   (140,000)
Asset retirement obligations incurred 7,000 1,000
Revisions to asset retirement obligations (198,000) $ 138,000
Capital expenditures included in accounts payable and accrued liabilities $ 9,000